Cargando…

Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis

BACKGROUND: Moderately hypofractionated whole-breast radiotherapy (HFRT) has proven to be as safe and efficient as normofractionated radiotherapy (NFRT) in randomized trials resulting in major changes in clinical practice. Toxicity rates observed in selected clinical trial patients may differ from t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Issoufaly, Irfane, Petit, Claire, Guihard, Sébastien, Eugène, Rémi, Jung, Loic, Clavier, Jean Baptiste, Servagi Vernat, Stéphanie, Bellefqih, Sara, Verret, Benjamin, Bonnet, Naïma, Deutsch, Éric, Rivera, Sofia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019802/ https://www.ncbi.nlm.nih.gov/pubmed/35443729 http://dx.doi.org/10.1186/s13014-022-02044-z

Ejemplares similares

Effectiveness of hypofractionated and normofractionated radiotherapy in a triple‐negative breast cancer model
por: Grosche, Sinja, et al.
Publicado: (2022)

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
por: Pelak, Maciej J., et al.
Publicado: (2022)

A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer
por: Borm, Kai J., et al.
Publicado: (2021)

Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer
por: Nakajima, Koichiro, et al.
Publicado: (2022)

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Alfredo, Conti, et al.
Publicado: (2019)

Correction to: Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Conti, Alfredo, et al.
Publicado: (2020)

Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3)
por: Sarria, Gustavo R., et al.
Publicado: (2022)

Cystic brain metastasis from prostate cancer: A case report and literature review
por: Marchand Crety, Charles, et al.
Publicado: (2020)

Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort
por: Bruand, Marie, et al.
Publicado: (2022)

Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines
por: Schatz, Julia, et al.
Publicado: (2022)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
por: Klement, Rainer J., et al.
Publicado: (2021)

MMAP-08 CHEMO-REIRRADIATION (NORMOFRACTIONATED VS. HYPOFRACTIONATED) WITH OR WITHOUT BEVACIZUMAB IN RECURRENT ADULT DIFFUSE HIGH-GRADE GLIOMA (COBRA): PHASE III RANDOMIZED CONTROLLED TRIAL WITH A 2 X 2 FACTORIAL DESIGN
por: Baviskar, Yamini, et al.
Publicado: (2022)

Anxiety during Radiation Therapy: A Prospective Randomized Controlled Trial Evaluating a Specific One-on-One Procedure Announcement Provided by a Radiation Therapist
por: Antoni, Delphine, et al.
Publicado: (2021)

Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE)
por: Servagi-Vernat, Stéphanie, et al.
Publicado: (2017)

Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy
por: Nguyen, Ludovic T., et al.
Publicado: (2013)

Early evaluation predicts pain relief of irradiated bone metastases: a single-center prospective study
por: Truntzer, Pierre, et al.
Publicado: (2013)

Adjuvant radiation therapy for malignant Abrikossoff’s tumor: a case report about a femoral triangle localisation
por: Marchand Crety, C., et al.
Publicado: (2018)

Efficacy of trabectedin in metastatic solitary fibrous tumor
por: Chaigneau, Loïc, et al.
Publicado: (2011)

Predictive Value of Early Post-Treatment Diffusion-Weighted MRI for Recurrence or Tumor Progression of Head and Neck Squamous Cell Carcinoma Treated with Chemo-Radiotherapy
por: Brenet, Esteban, et al.
Publicado: (2020)

Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy
por: Verlut, Clotilde, et al.
Publicado: (2016)

Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
por: Krug, David, et al.
Publicado: (2020)

Hypofractionation: less is more?
por: Mariam, Neethu Billy Graham, et al.
Publicado: (2021)

Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy
por: Alaghband, Yasaman, et al.
Publicado: (2023)

Selection for Favorable Health Traits: A Potential Approach to Cope with Diseases in Farm Animals
por: Hu, Guoyu, et al.
Publicado: (2020)

Urban farms in Miami-Dade county, Florida have favorable environments for vector mosquitoes
por: Wilke, André B. B., et al.
Publicado: (2020)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)

Moderate hypofractionation for prostate cancer
por: Lee, W. Robert, et al.
Publicado: (2018)

Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

Better Care Through Hypofractionation
por: Boisvert-Huneault, Christian, et al.
Publicado: (2022)

The Role of Hypofractionation in Proton Therapy
por: Santos, Alexandre, et al.
Publicado: (2022)

Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance
por: Hafeez, Shaista, et al.
Publicado: (2020)

Study protocol: a multicentre, prospective, phase II trial of isotoxic hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer
por: Liu, Yue-E, et al.
Publicado: (2020)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

Implementation and utilization of hypofractionation for breast cancer
por: Gilbo, Philip, et al.
Publicado: (2018)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Hypofractionation trials and radiobiology of prostate cancer
por: Gulliford, Sarah, et al.
Publicado: (2017)

Cost Minimization Analysis of Hypofractionated Radiotherapy
por: Yaremko, Hannah L., et al.
Publicado: (2021)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_svg2tklf93uk2foq616dkshk8s